Here are four things to know:
1. Mr. Turkaly set a $22 price target on K2M shares.
2. Last Friday, K2M shares closed at $13.81.
3. Analysts have a consensus rating of “strong buy” on K2M shares. Their average price target is $21.50.
4. On May 23, Needham analysts increased K2M’s rating to “buy,” and set a $21 price target.
More articles on devices:
Medtronic, K2M, J&J & more: 15 key notes
3 emerging trends that could impact the global spinal implants market
Global SCS market to grow to 2028: 5 insights
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
